Clinical Trial Update: AMS VS MOXI Ketek vs Avelox in AMS [Phase 3]

View source ↗

Summary

Sanofi-sponsored Phase 3 trial comparing Ketek (telithromycin) to Avelox (moxifloxacin) for acute maxillary sinusitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Maxillary Sinusitis

Drugs mentioned

• Avelox (moxifloxacin)
• Ketek (telithromycin)

Snippet

Sponsor: Sanofi | Conditions: Maxillary Sinusitis | Phase 3 | Status: COMPLETED